Susceptibility to Diphtheria among Vaccinated Children Aged 1–14 Years: A Serosurvey in a Rural Subdistrict, Bangladesh, 2019
DOI:
https://doi.org/10.59096/osir.v18i2.272083Keywords:
diptheria, immunity, serosurvey, vaccine, boosterAbstract
In Bangladesh, diphtheria vaccine is administered to children at six, ten and fourteen weeks of age, with no booster dose given up to 14 years. As antibody levels decrease over time, over five years may become susceptible to diphtheria. We conducted a serosurvey in a rural subdistrict among children aged 1–14 years to estimate the proportion of protected children, to determine the mean anti-diphtheria antibody concentration, and to identify factors associated with being unprotected in vaccinated children. We enrolled children who had completed their primary diphtheria vaccination and selected three age groups: 1–4 (n=422), 5–9 (n=518), and 10–14 years (n=402), using cluster sampling across in a selected rural subdistrict. We collected information on socio-demographic, environmental, maternal and birth-related characteristics, and vaccination history. Serum diphtheria antibody levels were measured by ELISA, with ≥0.1 IU/mL considered protective. We used chi-squared test and odds ratio to identify associated factors and applied multiple logistic regression to adjust for confounding. The proportion of protected children in the three age groups was 76% (1–4), 48% (5–9) and 36% (10–14). The geometric mean titer (GMT) of diphtheria antibody was highest in 1–4 years (0.18 IU/mL) and lowest 10–14 years (0.08 IU/mL). Being in older age groups were significantly associated with being unprotected. Over half of children aged 5–9 years and two-thirds of children aged 10–14 years were unprotected. We recommend introducing a booster dose of diphtheria vaccine for children over five years.
References
World Health Organization. The immunological basis for immunization series: module 2: diphtheria – update 2009 [Internet]. Geneva: World Health Organization; 2009 Jan [cited 2019 Jan 29]. 39 p. <https://apps.who.int/iris/bitstream/handle/10665/44094/9789241597869_eng.pdf;jsessionid=3CCC8E03F6E4710C5A608C1EAF5C04F9?sequence=1>
Maramraj KK, Latha MLK, Reddy R, Sodha SV, Kaur S, Dikid T, et al. Addressing Reemergence of Diphtheria among Adolescents through Program Integration in India. Emerg Infect Dis [Internet]. 2021 Mar [cited 2024 Jun 6];27(3):953–6. <https://doi.org/10.3201/eid2703.203205>
Clarke KEN, MacNeil A, Hadler S, Scott C, Tiwari TSP, Cherian T. Global epidemiology of diphtheria, 2000–20171. Emerg Infect Dis [Internet]. 2019 Oct [cited 2024 May 3];25(10):1834–42. <https://doi.org/10.3201/eid2510.190271>
Truelove SA, Keegan LT, Moss WJ, Chaisson LH, Macher E, Azman AS, et al. Clinical and epidemiological aspects of diphtheria: a systematic review and pooled analysis. Clin Infect Dis [Internet]. 2020 [cited 2024 Jun 6];71(1):89–97. <https://doi.org/10.1093/cid/ciz808>
World Health Organization. Diphtheria vaccines: WHO position paper – August 2017 [Internet]. Geneva: World Health Organization; 2017 [cited 2020 Feb 20]. 20 p. <https://apps.who.int/iris/bitstream/handle/10665/258681/WER9231.pdf;jsessionid=2DEDCD1CBD3627FD4407581FDC0125CA?sequence=1>
Polonsky JA, Ivey M, Mazhar MdKA, Rahman Z, le Polain de Waroux O, Karo B, et al. Epidemiological, clinical, and public health response characteristics of a large outbreak of diphtheria among the Rohingya population in Cox’s Bazar, Bangladesh, 2017 to 2019: A retrospective study. Spiegel P, editor. PLOS Med [Internet]. 2021 Apr 1 [cited 2021 Jun 30];18(4):e1003587. <https://doi.org/10.1371/journal.pmed.1003587>.
Knoema. Bangladesh Diphtheria cases, 1920–2020 [Internet]. New York: Knoema; [cited 2021 Sep 6]. <https://knoema.com//atlas/Bang ladesh/topics/Health/Communicable-Diseases/Diphtheria-cases>
World Health Organization. Diphtheria outbreak, Cox’s Bazar, Bangladesh – Daily Epidemiological Bulletin [Internet]. Geneva: reliefweb; 2017 Dec 26 [cited 2025 Jun 25]. 8 p. <https://reliefweb.int/report/bangladesh/diphtheria-outbreak-cox-s-bazar-bangladesh-daily-epidemiological-bulletin-2017-12>
Sarker AR, Akram R, Ali N, Sultana M. Coverage and factors associated with full immunisation among children aged 12–59 months in Bangladesh: insights from the nationwide cross-sectional demographic and health survey. BMJ Open [Internet]. 2019 Jul 9 [cited 2025 Jan 13];9(7):e028020. <https://doi.org/10.1136/bmjopen-2018-028020>
Boulton ML, Carlson BF, Power LE, Wagner AL. Socioeconomic factors associated with full childhood vaccination in Bangladesh, 2014. Int J Infect Dis [Internet]. 2018 Apr [cited 2025 Jan 13];69:35–40. <https://www.sciencedirect.com/science/article/pii/S1201971218300365>. doi:10.1016/j.ijid.2018.01.035.
World Health Organization. Immunization data [Internet]. Geneva: World Health Organization; [cited 2025 Jan 13]. <https://immunizationdata.who.int/global/wiise-detail-page>
World Health Organization; United Nations Children’s Fund. Replacement of TT with Td vaccine for dual protection [Internet]. Geneva: World Health Organization; 2018 Jun 28 [cited 2025 Jan 24]. 2 p. https://cdn.who.int/media/docs/default-source/immunization/who_unicef_joint_communique_on_tt_to_td_replacement_final28june2018.pdf?sfvrsn=1192f952_1>
Marti M. Diphtheria vaccine: review of evidence on vaccine effectiveness and immunogenicity to assess the duration of protection≥10 years after the last booster dose. [Internet]. Geneva: World Health Organization; [cited 2025 Jun 25]. 17 p. <https://terrance.who.int/mediacentre/data/sage/SAGE_Docs_Ppt_Apr2017/10_session_diptheria/Apr2017_session10_Presentation2_serological_immunogenicity.pdf>
Gao H, Lau EHY, Cowling BJ. Waning immunity after receipt of pertussis, diphtheria, tetanus, and polio-related vaccines: a systematic review and meta-analysis. J Infect Dis. 2022 Feb 15;225(4):557–66. doi:10.1093/infdis/jiab480.
World Health Organization. Diphtheria [Internet]. Geneva: World Health Organization; [cited 2025 Jan 14]. <https://www.who.int/teams/immunization-vaccines-and-biologicals/diseases/diphtheria>
Sunarno, Asri F, Subangkit, Mursinah, Herna, Nike S, et al. Diphtheria serology in adults in Central Java and East Java, Indonesia: the importance of continuous diphtheria vaccination. Afr Health Sci [Internet]. 2021 Sep [cited 2025 Jan 17];21(3):1148–54. <https://doi.org/10.4314/ahs.v21i3.23>
Directorate General of Health Services. EPI coverage evaluation survey 2019 [Internet]. Dhaka: World Health Organization Bangladesh; 2020 Dec [cited 2025 Jan 19]. 290 p. <https://old.dghs.gov.bd/images/docs/vpr/Coverage_Evaluation_Survey_2019.pdf>
Bangladesh Bureau of Statistics. District Statistics 2011 [Internet]. Dhaka: Bangladesh Bureau of Statistics; 2013 Dec [cited 2025 Jun 27]. 107 p. <https://bbs.portal.gov.bd/sites/default/files/files/bbs.portal.gov.bd/page/d6de1de2_346e_4444_8302_5de47d001d52/2025-06-26-06-02-ce0312459c992b917a1d2ec882243a07.pdf>
Gowin E, Wysocki J, Kaluzna E, Swiatek-Koscielna B, Wysocka-Leszczynska J, et al. Does vaccination ensure protection? Assessing diphtheria and tetanus antibody levels in a population of healthy children. Medicine (Baltimore) [Internet]. 2016 Dec [cited 2021 Sep 6];95(49):e5571. <https://doi.org/10.1097/MD.0000000000005571>
Mafuta EM, Lulebo AM, Kasonga JN, Mvuama NM, Luhata CL, Hoff NA, et al. Designing a National Rapid Vaccine Coverage Survey in low-resource settings: Experiences from the Democratic Republic of the Congo 2018–2023. Vaccine. 2025 Apr 19; 53:126956. doi:10.1016/j.vaccine.2025.126956.
Mohanty L, Sharma S, Behera B, Panwar S, Paliwal C, Singh A, et al. A randomized, open-label clinical trial to evaluate immunogenicity and safety of an indigenously developed DTwP-Hib tetravalent combination vaccine (Easyfour®-TT) with Quadrovax® in Indian infants. Hum Vaccines Immunother [Internet]. 2017 [cited 2025 Jan 21];13(9):2025–31. <https://doi.org/10.1080/21645515.2017.1342020>
Murhekar MV, Bitragunta S, Hutin Y, Ckakravarty A, Sharma HJ, Gupte MD. Immunization coverage and immunity to diphtheria and tetanus among children in Hyderabad, India. J Infect. 2009 Mar;58(3):191–6. doi:10.1016/j.jinf.2008.12.010.
Faruq A, Dadson L, Cox H, Alcock F, Parker AR. Technical and diagnostic performance of five commercial anti-diphtheria toxoid IgG enzyme-linked immunosorbent assay kits. Clin Vaccine Immunol [Internet]. 2010 Oct [cited 2025 Jan 21];17(10):1612–6. <https://doi.org/10.1128/CVI.00077-10>
Nicholson L, Adkins E, Karyanti MR, Ong-Lim A, Shenoy B, Huoi C, et al. What is the true burden of diphtheria, tetanus, pertussis and poliovirus in children aged 3–18 years in Asia? A systematic literature review. Int J Infect Dis [Internet]. 2022 [cited 2024 May 3];117:116–29. <https://www.ijidonline.com/article/S1201-9712(22)00053-4/fulltext>. doi:10.1016/j.ijid.2022.01.045.
Hanvatananukul P, Prasarakee C, Sarachai S, Aurpibul L, Sintupat K, Khampan R, et al. Seroprevalence of antibodies against diphtheria, tetanus, and pertussis among healthy Thai adolescents. Int J Infect Dis. 2020 Jul;96:422–30. doi:10.1016/j.ijid.2020.04.088.
Garelick H, Jones H. Mitigating arsenic pollution: bridging the gap between knowledge and practice. Chemistry international. 2008;30(4):7–12.
Ghorpade N. Diphtheria and tetanus antibody persistence in Indian pre-school children and response to a booster dose of DT vaccine. World J Vaccines [Internet]. 2011 [cited 2025 Jan 22];1:5–9. doi:10.4236/WJV.2011.11002.
Welch BM, Branscum A, Ahmed SM, Hystad P, Smit E, Afroz S, et al. Arsenic exposure and serum antibody concentrations to diphtheria and tetanus toxoid in children at age 5: A prospective birth cohort in Bangladesh. Environ Int [Internet]. 2019 Jun [cited 2024 May 31];127:810–8. <https://linkinghub.elsevier.com/retrieve/pii/S0160412018330435>. doi:10.1016/j.envint.2019.04.015.
Saha A, Chowdhury MI, Nazim M, Alam MM, Ahmed T, Hossain MB, et al. Vaccine specific immune response to an inactivated oral cholera vaccine and EPI vaccines in a high and low arsenic area in Bangladeshi children. Vaccine. 2013 Jan 11;31(4):647–52. doi:10.1016/j.vaccine.2012.11.049.
Malito E, Bursulaya B, Chen C, Surdo PL, Picchianti M, Balducci E, et al. Structural basis for lack of toxicity of the diphtheria toxin mutant CRM197. Proc Natl Acad Sci U S A. 2012 Apr 3;109(14):5229–34. doi:10.1073/pnas.1201964109.
McVernon J, MacLennan J, Clutterbuck E, Buttery J, Moxon ER. Effect of infant immunisation with meningococcus serogroup C–CRM197 conjugate vaccine on diphtheria immunity and reactogenicity in pre-school aged children. Vaccine. 2003 Jun;21(19–20):2573–9. doi:10.1016/s0264-410x(03)00058-6.
von Hunolstein C, Aggerbeck H, Andrews N, Berbers G, Fievet-Groyne F, Maple PA, et al. European sero-epidemiology network: standardisation of the results of diphtheria antitoxin assays. Vaccine. 2000 Aug 1;18(28):3287–96. doi:10.1016/s0264-410x(00)00125-0.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Outbreak, Surveillance, Investigation & Response (OSIR) Journal

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.




